About us
Advanced BioHealing, Inc. is an industry leader in the science of regenerative medicine. The Company is focused on the commercialization of cellular therapeutics, and currently markets the FDA-approved product Dermagraft®, indicated for diabetic foot ulcers.
Dermagraft
Dermagraft® is a cryopreserved human fibroblast-derived dermal substitute; it is composed of fibroblasts, extracellular matrix, and a bioabsorbable scaffold. Is manufactured from human fibroblast cells derived from newborn foreskin tissue.
More than half of all foot ulcers (wounds) will become infected, requiring hospitalization and 1 in 5 will require an amputation.